Comparison of Glargine to Degludec Insulin Transition With or Without a Bridging Glargine Dose
Status:
Recruiting
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
This study evaluates direct switching vs use of a bridging dose from insulin glargine to
insulin degludec in type 1 DM patients. Half of the participants will receive a bridging
insulin glargine dose along with the 1st dose of degludec, while other half will receive a
placebo and 1st dose of degludec.